Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jan;105(1):51–58. doi: 10.1111/j.1476-5381.1992.tb14209.x

The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.

G A McPherson 1, A P Stork 1
PMCID: PMC1908611  PMID: 1534504

Abstract

1. Cromakalim (0.01-30 microM) and sodium nitroprusside (SNP, 0.01-100 microM) were tested for their ability to relax a number of pre-contracted small arteries (approximate diameter 200-700 microM at 100 mmHg) from the rat, rabbit and guinea-pig. 2. In the rat, SNP (0.01-100 microM) caused near maximal relaxation in all vessels studied including the middle cerebral, anterior cerebellar, basilar, mesenteric and renal arteries. Cromakalim (0.01-30 microM) relaxed pre-contracted mesenteric and renal arteries but was only a weak relaxant of all the rat cerebral arteries with the exception of the basilar artery. Similar experiments using mesenteric and cerebral vessels from the rabbit and guinea-pig showed cromakalim could relax pre-contracted vessels in a concentration-dependent manner. 3. Two other K+ channel openers, nicorandil and pinacidil, were also tested for their ability to relax rat cerebral arteries. Nicorandil (0.01-100 microM) was ineffective in the rat anterior cerebellar artery at concentrations up to 100 microM. Pinacidil (0.01-100 microM) caused significant vasorelaxation, although high concentrations were required (greater than 10 microM) and the response was insensitive to the effects of glibenclamide (3 microM). 4. Electrophysiological experiments with the rat anterior cerebellar artery showed that cromakalim (up to 30 microM) failed to influence the resting membrane potential of impaled single smooth muscle cells. 5. The results showed that some rat small cerebral arteries were resistant to the effects of K+ channel openers including cromakalim, pinacidil and nicorandil. This is peculiar to this vascular tree since the same vessels from other species do not exhibit the same behaviour.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angerbach D., Nicholson C. D. Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease. Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):341–346. doi: 10.1007/BF00168848. [DOI] [PubMed] [Google Scholar]
  2. Angus J. A., Broughton A., Mulvany M. J. Role of alpha-adrenoceptors in constrictor responses of rat, guinea-pig and rabbit small arteries to neural activation. J Physiol. 1988 Sep;403:495–510. doi: 10.1113/jphysiol.1988.sp017260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buckingham R. E., Clapham J. C., Hamilton T. C., Longman S. D., Norton J., Poyser R. H. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):798–804. doi: 10.1097/00005344-198709010-00022. [DOI] [PubMed] [Google Scholar]
  4. Buckingham R. E. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine. Br J Pharmacol. 1988 Mar;93(3):541–552. doi: 10.1111/j.1476-5381.1988.tb10309.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cocks T. M., Angus J. A. Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside. Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):364–372. doi: 10.1007/BF00180663. [DOI] [PubMed] [Google Scholar]
  6. Edwards F. R., Hirst G. D., Silverberg G. D. Inward rectification in rat cerebral arterioles; involvement of potassium ions in autoregulation. J Physiol. 1988 Oct;404:455–466. doi: 10.1113/jphysiol.1988.sp017299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edwards G., Weston A. H. Structure-activity relationships of K+ channel openers. Trends Pharmacol Sci. 1990 Oct;11(10):417–422. doi: 10.1016/0165-6147(90)90149-3. [DOI] [PubMed] [Google Scholar]
  8. Hamilton T. C., Weir S. W., Weston A. H. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986 May;88(1):103–111. doi: 10.1111/j.1476-5381.1986.tb09476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hof R. P., Quast U., Cook N. S., Blarer S. Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers. Circ Res. 1988 Apr;62(4):679–686. doi: 10.1161/01.res.62.4.679. [DOI] [PubMed] [Google Scholar]
  10. Ksoll E., Parsons A. A., Mackert J. R., Schilling L., Wahl M. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Naunyn Schmiedebergs Arch Pharmacol. 1991 Apr;343(4):377–383. doi: 10.1007/BF00179042. [DOI] [PubMed] [Google Scholar]
  11. McPherson G. A. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J Pharmacol Methods. 1985 Nov;14(3):213–228. doi: 10.1016/0160-5402(85)90034-8. [DOI] [PubMed] [Google Scholar]
  12. McPherson G. A., Angus J. A. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol. 1990 Jun;100(2):201–206. doi: 10.1111/j.1476-5381.1990.tb15782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McPherson G. A., Angus J. A. Evidence that acetylcholine-mediated hyperpolarization of the rat small mesenteric artery does not involve the K+ channel opened by cromakalim. Br J Pharmacol. 1991 May;103(1):1184–1190. doi: 10.1111/j.1476-5381.1991.tb12321.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McPherson G. A., Angus J. A. Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromromakalim. Br J Pharmacol. 1989 Jul;97(3):941–949. doi: 10.1111/j.1476-5381.1989.tb12035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  16. Nagao T., Sadoshima S., Kamouchi M., Fujishima M. Cromakalim dilates rat cerebral arteries in vitro. Stroke. 1991 Feb;22(2):221–224. doi: 10.1161/01.str.22.2.221. [DOI] [PubMed] [Google Scholar]
  17. Parsons A. A., Ksoll E., Mackert J. R., Schilling L., Wahl M. Comparison of cromakalim-induced relaxation of potassium precontracted rabbit, cat, and rat isolated cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol. 1991 Apr;343(4):384–392. doi: 10.1007/BF00179043. [DOI] [PubMed] [Google Scholar]
  18. Shoji T., Aki Y., Fukui K., Tamaki T., Iwao H., Abe Y. Effects of cromakalim, a potassium channel opener, on regional blood flow in conscious spontaneously hypertensive rats. Eur J Pharmacol. 1990 Sep 4;186(1):119–123. doi: 10.1016/0014-2999(90)94067-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES